Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 483

Similar articles for PubMed (Select 15354734)

1.

Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.

Uherova P, Olson S, Thompson MA, Juskevicius R, Hamilton KS.

Appl Immunohistochem Mol Morphol. 2004 Jun;12(2):105-10.

PMID:
15354734
2.

Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.

Churchill HR, Roncador G, Warnke RA, Natkunam Y.

Hum Pathol. 2010 Dec;41(12):1726-34. doi: 10.1016/j.humpath.2010.05.010. Epub 2010 Sep 9.

PMID:
20825974
3.

[Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].

Liu YH, Zhuang HG, Lin HL, Wu QL, Luo DL, Li L, Luo XL.

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):594-8. Chinese.

PMID:
17243292
4.

Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.

Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA.

Am J Surg Pathol. 2003 Oct;27(10):1346-56.

PMID:
14508396
5.

Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.

Xiao Q, Shen N, Hedvat CV, Moskowitz CH, Sussman LK, Filippa DA, Zelenetz AD, Houldsworth J, Chaganti RS, Teruya-Feldstein J.

Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):211-5.

PMID:
15551733
6.
7.

Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation.

van Houdt IS, Muris JJ, Hesselink AT, Kramer D, Cillessen SA, Moesbergen LM, Vos W, Hooijberg E, Meijer CJ, Kummer JA, Oudejans JJ.

Histopathology. 2007 Dec;51(6):778-84.

PMID:
18042067
8.
9.

Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma.

Zhou XD, Yu JP, Liu J, Luo HS, Chen HX, Yu HG.

Clin Sci (Lond). 2004 Apr;106(4):397-405.

PMID:
14636156
10.

[Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].

Wang JF, Wang YZ, Chen ZW, Taylor RC.

Zhonghua Bing Li Xue Za Zhi. 2006 Apr;35(4):218-23. Chinese.

PMID:
16776979
11.

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

Muris JJ, Cillessen SA, Vos W, van Houdt IS, Kummer JA, van Krieken JH, Jiwa NM, Jansen PM, Kluin-Nelemans HC, Ossenkoppele GJ, Gundy C, Meijer CJ, Oudejans JJ.

Blood. 2005 Apr 1;105(7):2916-23. Epub 2004 Dec 2.

13.

Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.

Liso A, Capello D, Marafioti T, Tiacci E, Cerri M, Distler V, Paulli M, Carbone A, Delsol G, Campo E, Pileri S, Pasqualucci L, Gaidano G, Falini B.

Blood. 2006 Aug 1;108(3):1013-20. Epub 2006 Apr 13.

14.

IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.

Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S.

Am J Surg Pathol. 2006 May;30(5):585-92.

PMID:
16699312
15.

Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.

Mourad WA, Al Thani S, Tbakhi A, Al Omari M, Khafaga Y, Shoukri M, El Weshi A, Al Shabana M, Ezzat A.

Hematol Oncol Stem Cell Ther. 2008 Jan-Mar;1(1):22-7.

PMID:
20063524
16.

Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.

Miles RR, Mankey CC, Seiler CE 3rd, Smith LB, Teruya-Feldstein J, Hsi ED, Elenitoba-Johnson KS, Lim MS.

Hum Pathol. 2009 Dec;40(12):1731-7. doi: 10.1016/j.humpath.2009.05.009. Epub 2009 Aug 27.

PMID:
19716163
17.
18.

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F, Aguiar RC, Li S, Salles G, Berger F, Jing W, Pinkus GS, Habermann T, Dalla-Favera R, Harris NL, Aster JC, Golub TR, Shipp MA.

Blood. 2003 Dec 1;102(12):3871-9. Epub 2003 Aug 21.

19.

c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.

Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA.

Urology. 2004 Jun;63(6):1198-204.

PMID:
15183989
20.

IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.

Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Müller-Hermelink HK, Ott G, Fend F, Rosenwald A.

Am J Surg Pathol. 2007 Oct;31(10):1605-14.

PMID:
17895764
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk